04:55
Unknown
Sterling Biotech’s existing Bond Holders at its meeting held on November 20, 2013, have approved for the conversion price of the Bonds, due 2018 to be at Rs. 60 per share, subject to Reserve Bank of India, Foreign Investment Promotion Board and such other regulatory approvals, if any, as may be required.
Posted in: Indian Market Tips
0 comments:
Post a Comment